Report overview
Cervical liquid-based cell artificial intelligence screening system Cervical-Sight utilizes deep learning technology based on convolutional neural network, which can realize automatic analysis of cervical liquid-based cell images, rapid screening and localization of diseased cells, and can detect diseased cells according to TBS guidelines. classification, and detection of microbial infections. Diagnosis is made through intelligent analysis, and finally a detection report is generated.
This report contains market size and forecasts of Liquid-based Cell Cervical Cancer Artificial Intelligence Screener in global, including the following market information:
Global Liquid-based Cell Cervical Cancer Artificial Intelligence Screener Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Liquid-based Cell Cervical Cancer Artificial Intelligence Screener Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Liquid-based Cell Cervical Cancer Artificial Intelligence Screener companies in 2021 (%)
The global Liquid-based Cell Cervical Cancer Artificial Intelligence Screener market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Flow Cytometer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liquid-based Cell Cervical Cancer Artificial Intelligence Screener include Hologic, Imsightmed, SenseTime, Landing Medical, Cells Vision Technology, BD, Jiulu Biotechnology, Guangzhou Anbiping Pharmaceutical Technology and Ingenuity System, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Liquid-based Cell Cervical Cancer Artificial Intelligence Screener manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liquid-based Cell Cervical Cancer Artificial Intelligence Screener Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Liquid-based Cell Cervical Cancer Artificial Intelligence Screener Market Segment Percentages, by Type, 2021 (%)
Flow Cytometer
Blood Cell Analyzer
Global Liquid-based Cell Cervical Cancer Artificial Intelligence Screener Market, by Sale Channel, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Liquid-based Cell Cervical Cancer Artificial Intelligence Screener Market Segment Percentages, by Sale Channel, 2021 (%)
Hospital
Clinic
Research Laboratory
Others
Global Liquid-based Cell Cervical Cancer Artificial Intelligence Screener Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Liquid-based Cell Cervical Cancer Artificial Intelligence Screener Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liquid-based Cell Cervical Cancer Artificial Intelligence Screener revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Liquid-based Cell Cervical Cancer Artificial Intelligence Screener revenues share in global market, 2021 (%)
Key companies Liquid-based Cell Cervical Cancer Artificial Intelligence Screener sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Liquid-based Cell Cervical Cancer Artificial Intelligence Screener sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hologic
Imsightmed
SenseTime
Landing Medical
Cells Vision Technology
BD
Jiulu Biotechnology
Guangzhou Anbiping Pharmaceutical Technology
Ingenuity System
Huayin Health
Mcaudi
